DIABETIC RETINOPATHY CHALLENGES IN DEVELOPING COUNTRIES: AWARENESS AND SEVERITY AT PRESENTATION OF DIABETIC RETINOPATHY AND BARRIERS TO ITS TREATMENT
Abstract
Background: Diabetic retinopathy is a common cause of visual loss in diabetic patients. Diabetic population is increasing throughout the world and Pakistan ranked third in the world in terms of diabetic population. Pakistan is having the highest 26.7% prevalence of diabetes 2022. The objective of the study was to document the first presentation of severity of diabetic retinopathy, presence of macular edema, referral and the patient awareness about the risk factors of development and progression of diabetic retinopathy in our population presenting to Khyber Teaching Hospital, Peshawar.
Materials & Methods: It was a descriptive study carried out in Ophthalmology Department of Khyber Teaching Hospital Peshawar from June 2023 to November 2023. Patients who presented for the first time to ophthalmologists were included in the study. Total of 340 patients with 680 eyes were enrolled in the study.
Results: There was no diabetic retinopathy in 189 eyes (27.8%), mild non-proliferative diabetic retinopathy in 213 eyes (31.3%), moderate non-proliferative diabetic retinopathy in 104 (15.29%) eyes, proliferative diabetic retinopathy in 76 (11.2%) and advanced diabetic eye disease (ADED) in 37 (5.4%) eyes. Only 19.70% patients were referred by endocrinologist, 12.25% by physician and 3.52% by general physician. The most common barrier to the treatment of diabetic retinopathy was lack of awareness about the disease (71.17%) followed by affordability (42.94%), transportation (21.17%), dependency (12.64%).
Conclusion: Health education about diabetic retinopathy is important for the patient but along with patients treating physician and endocrinologist need to be made aware about this blinding disease for proper referral and timely management.
Keywords
Full Text:
PDFReferences
Dugalic S, Petronijevic M, Vasiljevic B, Todorovic J, Stanisavljevic D, Jotic A. Trends of the prevalence of pre-gestational diabetes in 2030 and 2050 in Belgrade cohort. Int J Environ Res Public Health. 2022;19(11):6517. https://doi.org/10.3390/ijerph19116517
Azeem S, Khan U, Liaqat A. The increasing rate of diabetes in Pakistan: A silent killer. Ann Med Surg. 2022;79:103901. https://doi.org/10.1016/j.amsu.2022.103901
Bhutta ZA, Haq ZU, Basit A. Diabetes in Pakistan: Addressing the crisis. Lancet Diabetes Endocrinol. 2022;10(5):309-10. https://doi.org/10.1016/S2213-8587(22)00102-4
Akhtar H, Hassan F, Saqlain SR, Ali A, Hussain S. The prevalence of peripheral neuropathy among patients with diabetes in Pakistan: a systematic review and meta-analysis. Sci Rep. 2023;13(1):11744. https://doi.org/10.1038/s41598-023-39037-1
Servat OS, Hernandez C, Simo R. Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Res. 2019;62(4):211-7. https://doi.org/10.1159/000499541
Kumar R, Rehman S, Baloch GM, Vankwani M, Somrongthong R, Pongpanich S. Effectiveness of health education intervention on diabetes mellitus among the teachers working in public sectors schools in Pakistan. BMC Endocr Disord. 2022;22(1):194-8. https://doi.org/10.1186/s12902-022-01110-7
McMaughan DJ, Oloruntoba O, Smith ML. Socioeconomic status and access to healthcare: Inter-related drivers for healthy aging. Front Public Health. 2020;8:231-4. https://doi.org/10.3389/fpubh.2020.00231
Wali AS, Rafique R, Iftikhar S, Ambreen R, Yakoob MY. High proportion of overt diabetes mellitus in pregnancy and missed opportunity of early detection of diabetes at a tertiary care center of Pakistan. Pak J Med Sci. 2020;36(1):S38-S43. https://doi.org/10.12669/pjms.36.ICON-Suppl.1723
Al-Shehri AM, Aldihan KA, Aljohani S. Reasons for the late presentation of diabetic retinopathy in Saudi Arabia: A survey of patients who presented with advanced proliferative diabetic retinopathy to a tertiary eye hospital. Clin Ophthalmol. 2022;16:4323-33. https://doi.org/10.2147/OPTH.S394146
Piyasena PN, Murthy VS, Yip JL, Gilbert C, Zuurmond M, Peto T, et al. Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings. PLoS One. 2019;14(4):e0198979. https://doi.org/10.1371/journal.pone.0198979
Piyasena PN, Murthy VS, Yip JL, Gilbert C, Zuurmond M. A qualitative study on barriers and enablers to uptake of diabetic retinopathy screening by people with diabetes in the western province of Sri Lanka. Trop Med Health. 2019;47:9. https://doi.org/10.1186/s41182-019-0160-y
Middleton TL, Constantino MI, Molyneaux L, Souza MD, Twigg SM, Wu T, et al. Young onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications. Diabet Med. 2020;37(6):991-9. https://doi.org/10.1111/dme.14238
Javed A, Rehman HU. The association of elevated serum lipid with occurrence and severity of diabetic retinopathy in type II diabetics presenting in a tertiary care hospital. J Coll Physicians Surg Pak. 2022;32(3):401-3. https://doi.org/10.29271/jcpsp.2022.03.401
Mohammadi M, Raiegani AAV, Jalali R, Ghobadi A, Salari N. The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis. Rev Endocr Metab Disord. 2019;20(1):79-88. https://doi.org/10.1007/s11154-019-09490-3
Avidor D, Loewenstein A, Waisbourd M, Nutman A. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review. Cost Eff Resour Alloc. 2020;18:16-20. https://doi.org/10.1186/s12962-020-00211-1
Browning DJ, Stewart MW, Lee C. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol. 2018;66(12):1736-50. https://doi.org/10.4103/ijo.IJO_1240_18
Furino C, Boscia F, Reibaldi M, Alessio G. Intravitreal therapy for diabetic macular edema: An update. J Ophthalmol. 2021;6654168. https://doi.org/10.1155/2021/6654168
Rizwan A, Sufyan A, Asghar A, Khan H, Ahmad B, Rabbani MH. Awareness of diabetic retinopathy among diabetic patients. J Pak Med Assoc. 2021;71(2):651-5.
Kumar A, Agarwal D, Kumar A. Diabetic retinopathy screening and management in India: Challenges and possible solutions. Indian J Ophthalmol. 2021;69(3):479-81. https://doi.org/10.4103/ijo.IJO_2357_20
Wong TY, Sabanayagam C. The war on diabetic retinopathy: Where are we now? Asia Pac J Ophthalmol. 2019;8(6):448-56. https://doi.org/10.1097/APO.0000000000000267
DOI: https://doi.org/10.46903/gjms/22.03.1573
Refbacks
- There are currently no refbacks.
Copyright (c) 2024. Imran Ahmad, Nazli Gul, Bilal Khan, Jawad Humayun, Jahandad Khan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Gomal Medical College, Daraban Road, Dera Ismail Khan, Pakistan
ISSN: 1819-7973, e-ISSN: 1997-2067
Website: https://www.gmcdikhan.edu.pk
Phone: +92-966-747373


